Evidence map›Paper›PMID 34565446›Full record

ArticleJournal of medical case reports2021

A renal angiomyolipoma with a challenging presentation: a case report.

H Bouaziz, M Ghalleb, N Tounsi, N Riahi, H Bouzaiene, J Ziadi, J Ben Hassouna, M Slimane, K Rahal

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

H BouazizUniversity of Tunis ElManar, Tunis, Tunisia.
M GhallebUniversity of Tunis ElManar, Tunis, Tunisia. montaghalleb@gmail.com.
N TounsiDepartment of Surgical Oncology, Salah Azaiez Institute, 1062, Tunis, Tunisia.
N RiahiUniversity of Tunis ElManar, Tunis, Tunisia.
H BouzaieneUniversity of Tunis ElManar, Tunis, Tunisia.
J ZiadiDepartment of Surgical Oncology, Salah Azaiez Institute, 1062, Tunis, Tunisia.
J Ben HassounaUniversity of Tunis ElManar, Tunis, Tunisia.
M SlimaneUniversity of Tunis ElManar, Tunis, Tunisia.
K RahalUniversity of Tunis ElManar, Tunis, Tunisia.
Tunis El Manar University · TNInstitut Salah-Azaïz · TNHôpital La Rabta · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRenal angiomyolipoma is considered a benign mesenchymal tumor composed of fat, smooth muscle, and blood vessels. It represents 1-3% of solid renal tumors. Despite this tumor's benignity, it can be aggressive with a locoregional extension. CASE REPORT: A 41-year-old north African caucasian woman consulted with chief complaints of right lower back pain with no hematuria and no urinal sign. Thoracic-abdominopelvic contrast-enhanced computed tomography showed a right inferior polar heterogeneous renal mass complicated with venous thrombus ascending to the right atrium level. The patient underwent radical nephrectomy under extracorporeal circulation and direct supervision of the fatty thrombus at the right atrium level. The postoperative period was uneventful. The final histologic examination was concordant with renal angiomyolipoma.

conclusionRenal angiomyolipoma is the most common benign kidney tumor. Despite its benignity, it can be associated with lethal complications such as hemorrhage, and it can also show signs of local extension mimicking malignant tumors. The cornerstone of the treatment remains surgery.

Indexed as

AngiomyolipomaKidney NeoplasmsThrombosisAdultFemaleHumansKidneyNephrectomyAngiolipomaCardiac surgeryNephrectomyVenous thrombosis

Identifiers

PMID34565446
PMCPMC8474819
OpenAlexW3204727663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.